| Title: | Proteomic predictors of mortality among people with Coronary Artery Disease |
| Journal: | American Journal of Preventive Cardiology |
| Published: | 8 Nov 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/41399470/ |
| DOI: | https://doi.org/10.1016/j.ajpc.2025.101347 |
Publication 16808
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Background: Coronary artery disease (CAD) continues to pose a significant global health challenge, highlighting the crucial need to enhance prognostic accuracy and improve mortality outcomes for CAD management. Proteomics offers a nuanced perspective on the molecular intricacies underlying CAD progression. This study investigates proteomic profiles in people with CAD, aiming to identify protein markers associated with mortality outcomes.</p>
Methods: Utilizing the UK Biobank (UKB) and the Mental Stress Ischemia Prognosis Study (MIPS), the study analyzed proteomic data from 2768 CAD participants in the UKB and 91 CAD participants in the MIPS. Cox proportional hazards models, LASSO regression, and pathway enrichment analysis were employed to identify proteomic predictors of all-cause mortality. A proteomics score was derived using the LASSO-selected proteins.</p>
Results: Out of 1696 tested proteins, 341 were associated with all-cause mortality in the UKB. Seventeen proteins were selected by LASSO, with GDF15 and ANGPT2 validated in the MIPS. One standard deviation higher in the proteomics score was associated with all-cause mortality in both the UKB (HR 2.37, 95 % CI 2.17 - 2.59, p 4.04 × 10-84) and the MIPS (HR 6.93, 95 % CI 3.29 - 14.58, p 3.52 × 10-7). Mortality-associated proteins revealed enrichment in pathways related to inflammation and cellular adhesion.</p>
Conclusion: This study expands our understanding of CAD prognosis by uncovering potential proteomic biomarkers. The development and validation of the proteomics score in two independent CAD cohorts in the UK and the US underscore the potential utility for enhancing prognostic precision in the context of CAD.</p>
5 Authors
- Chang Liu
- Qin Hui
- Arshed A Quyyumi
- Viola Vaccarino
- Yan V Sun
1 Application
| Application ID | Title |
|---|---|
| 34031 | Integrative study of genomic, environmental, and clinical factors for cardio-metabolic diseases |
Enabling scientific discoveries that improve human health